EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial

Kosuke Kojima, Yohei Kamata iD, Tomoko Shimizu, Satsuki Sato, Sota Suzuki, Yuya Takanashi, Sawako Hojo, Takeshi Yoshino, Shinya Fuchida, Toshiyuki Tamura, Masato Minabe, Toshiro Kodama und 2 weitere

Journal of Periodontal Research · 2024

DOI: 10.1111/jre.13310 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontal Research, 2024. Verfasst von Kosuke Kojima und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Implantology and Periodontology, Graduate School of Dentistry, Kanagawa Dental University, Yokohama, Kanagawa, Japan. Hauptthemen laut MEDLINE: Fibroblast Growth Factor 2, Recombinant Proteins, Alveolar Bone Loss, Guided Tissue Regeneration, Periodontal. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To compare the outcomes of therapy using recombinant human fibroblast growth factor (rhFGF)‐2 combined with autologous bone grafting (ABG) therapy with those of rhFGF‐2 alone and ABG alone in the treatment of periodontal intraosseous defects.

Methods

Periodontal intraosseous defects were randomized to receive rhFGF‐2 therapy + ABG, rhFGF‐2 therapy alone, or ABG alone. Periodontal examination and periapical radiography were performed preoperatively and at 3, 6, and 12 months postoperatively.

Results

At the 12 months follow‐up, all three groups showed significant improvement in the clinical attachment level (CAL): 5.6 ± 1.6, 5.8 ± 1.7, and 5.2 ± 1.6 mm in the rhFGF‐2 + ABG, rhFGF‐2 alone, and ABG alone groups, respectively, with no significant inter‐group differences ( p < .05). rhFGF‐2 therapy (alone or in combination) resulted in greater bone defect filling (BDF) (2.3 ± 1.2 mm and 2.6 ± 1.9 mm, respectively) than ABG therapy alone (1.2 ± 1.2 mm). Gingival recession was lesser in the ABG alone (1.2 ± 1.1 mm) and rhFGF‐2 + ABG groups (1.4 ± 0.8 mm) than in the rhFGF‐2 alone group (2.2 ± 1.2 mm).

Conclusion

The results of this study showed that at 12 months postoperatively, all treatments resulted in statistically significant clinical improvements compared to the baseline. From these results, it can be concluded that rhFGF‐2 promotes hard tissue regeneration in intraosseous defects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor 2Recombinant ProteinsAlveolar Bone LossGuided Tissue Regeneration, PeriodontalHumansMaleFemaleMiddle AgedAdultBone TransplantationBone RegenerationTreatment OutcomeCombined Modality TherapyFollow-Up Studies

Stichwörter der Autor:innen

alveolar bone graftingclinical attachment levelfibroblast growth factorperiodontal intraosseous defectsperiodontal pocket

Substanzen

Fibroblast Growth Factor 2Recombinant Proteins

Autor:innen und Institutionen

  • Department of Implantology and Periodontology, Graduate School of Dentistry, Kanagawa Dental University, Yokohama, Kanagawa, Japan.
  • Department of Education Planning, Kanagawa Dental University, Yokosuka, Japan.
  • Bunkyodori Dental Clinic, Chiba, Japan.
  • Department of Gastroenterology, International University Health and Welfare Graduate School of Medicine, Chiba, Japan.
  • Department of Biostatistics, JORTC Data Center 2-54-6-302, Tokyo, Japan.

ORCID-Profile: Yohei Kamata

Zitieren

APA

Kojima, K., Kamata, Y., Shimizu, T., Sato, S., Suzuki, S., Takanashi, Y., Hojo, S., Yoshino, T., Fuchida, S., Tamura, T., Minabe, M., Kodama, T., Kessoku, T., & Oyamada, S. (2024). Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial. Journal of Periodontal Research. https://doi.org/10.1111/jre.13310

Vancouver

Kojima K, Kamata Y, Shimizu T, Sato S, Suzuki S, Takanashi Y, et al. Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial. Journal of Periodontal Research. 2024. doi:10.1111/jre.13310

BibTeX
@article{Kojima2024,
  author = {Kojima, Kosuke and Kamata, Yohei and Shimizu, Tomoko and Sato, Satsuki and Suzuki, Sota and Takanashi, Yuya and Hojo, Sawako and Yoshino, Takeshi and Fuchida, Shinya and Tamura, Toshiyuki and Minabe, Masato and Kodama, Toshiro and Kessoku, Takaomi and Oyamada, Shunsuke},
  title = {Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial},
  journal = {Journal of Periodontal Research},
  year = {2024},
  doi = {10.1111/jre.13310}
}
Kostenlos starten →